Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Henan Biosio Biotech is a biotechnology company based in Zhengzhou, China, specializing in the development and production of raw materials for the in vitro diagnostics (IVD) industry. The company provides a comprehensive range of high-purity enzymes, antigens, and antibodies essential for molecular and immunological testing. Their product portfolio is particularly strong in infectious disease diagnostics, featuring critical components for COVID-19, influenza, and hepatitis assays. In addition to diagnostic reagents, they offer specialized enzymes for PCR, qPCR, and next-generation sequencing (NGS) applications. Henan Biosio Biotech operates large-scale manufacturing facilities that adhere to strict quality management standards to support global diagnostic kit manufacturers. The company is recognized for its R&D capabilities in protein engineering and antibody development, positioning it as a key upstream partner in the life sciences industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Henan Biosio Biotech.